Latest filingSep 03, 2026Most recent Form 4
RIGL
RIGEL PHARMACEUTICALS INC
Insider activity for last month from 08/04 to 09/04. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$00 sells
Net open-market+$04 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period12transactions
- M · Option exercise · dominant8 · 67%
- F · Tax withholding4 · 33%
Activity by reported role
A joint filing can contribute to multiple roles26transactions
- EVP · dominant11 · 42%
- Chief financial officer9 · 35%
- CCO2 · 8%
- Chief executive officer1 · 4%
- CS1 · 4%
- GC1 · 4%
- PRES1 · 4%
Distinct insiders active
Reporting-owner CIKs by month · peak Sep 2026 (4)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeSchorno Dean LCommon Stock · Direct
79,676Sep 02, 2026
Schorno Dean LEmployee Stock Option (right to buy) · Direct
12,824Sep 02, 2026
Furey Raymond J.Common Stock · Direct
50,559Sep 01, 2026
Rodriguez Raul RCommon Stock · Direct
273,362Sep 01, 2026
Santos David ACommon Stock · Direct
61,622Sep 01, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 04 → Sep 04
LessMore
Top insiders
By absolute net value across the selected period- RR-$115.1k
- SL+$55.8k
- FJ-$41.7k
- SA-$41.5k
Recent filing activity
Most recent 12 transactions · color = transaction code- MOption exercise09/03$0SEC
- MOption exercise09/03$0SEC
- MOption exercise09/03$0SEC
- MOption exercise09/03$0SEC
- MOption exercise09/03$3.11MSEC
- MOption exercise09/03$4.84MSEC
- MOption exercise09/03$1.15MSEC
- MOption exercise09/03$881kSEC
- FTax withholding09/03-$4.40MSEC
- FTax withholding09/03-$4.15MSEC
- FTax withholding09/03-$11.5MSEC
- FTax withholding09/03-$4.16MSEC
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
No filing-only signal badges matched this period.
RIGL transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| RIGL | Schorno Dean L | EVPCFO | exercise | 1.28k | $0 | M | — | 0.0% | 09/03 | 09/02 |
| RIGL | Schorno Dean L | EVPCFO | exercise | 2.00k | $0 | M | — | 0.0% | 09/03 | 09/02 |
| RIGL | Schorno Dean L | EVPCFO | exercise | 620 | $0 | M | — | 0.0% | 09/03 | 09/02 |
| RIGL | Schorno Dean L | EVPCFO | exercise | 694 | $0 | M | — | 0.0% | 09/03 | 09/02 |
| RIGL | Schorno Dean L | EVPCFO | exercise | 1.28k | $3.11M | M | — | 0.0% | 09/03 | 09/02 |
| RIGL | Schorno Dean L | EVPCFO | exercise | 2.00k | $4.84M | M | — | 0.0% | 09/03 | 09/02 |
| RIGL | Schorno Dean L | EVPCFO | exercise | 620 | $1.15M | M | — | 0.0% | 09/03 | 09/02 |
| RIGL | Schorno Dean L | EVPCFO | exercise | 694 | $881k | M | — | 0.0% | 09/03 | 09/02 |
| RIGL | Schorno Dean L | EVPCFO | withholding | 928 | -$4.40M | F | — | 0.0% | 09/03 | 09/01 |
| RIGL | Santos David A | EVPCCO | withholding | 874 | -$4.15M | F | — | 0.0% | 09/03 | 09/01 |
| RIGL | RODRIGUEZ RAUL R | CEOPRES | withholding | 2.42k | -$11.5M | F | — | 0.0% | 09/03 | 09/01 |
| RIGL | Furey Raymond J. | EVPGCCCO+1 | withholding | 877 | -$4.16M | F | — | 0.0% | 09/03 | 09/01 |
RIGEL PHARMACEUTICALS INC Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at RIGEL PHARMACEUTICALS INC?
Schorno Dean L, Santos David A, RODRIGUEZ RAUL R, Furey Raymond J..
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
No code-S sale is available for this period.
What is the recent purchase and sale balance?
No code-P purchases or code-S sales were reported in the selected period.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.